OrganiGram Pays Next $2.5M To Cannabis Biotech Firm Hyasynth
J&J Prepares To Restart US Covid-19 Vaccine Trial Recruitment
Weekly Market Review: Marking Time Ahead of Election
AstraZeneca Gets FDA Nod To Resume US Covid-19 Trial
FDA Approves Gilead's Remdesivir To Treat COVID-19 Despite Data Showing Drug Doesn't Work
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Gilead’s remdesivir finally gets US approval
Macro Briefing: 23 October 2020
Gilead’s Covid-19 Remdesivir Drug Scores FDA Approval; Shares Surge
FDA Grants Full Approval to Remdesivir for Covid-19
Roche wades deeper into Covid-19 fight, inking antiviral pact with $350M cash following Regeneron deal
Roche to co-develop remdesivir rival in partnership with Atea
Gilead Disputes WHO Data Confirming COVID-19 Drug Remdesivir Is A "Flop"
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
Pfizer Plans To Apply For FDA's Emergency-Use Approval During Third Week Of November, CEO Says
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
Macro Briefing: 16 October 2020
Novel antiviral strategy for treatment of COVID-19
Regeneron Scores FDA Nod For Ebola Treatment
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
EU makes 1 billion euro bet on Gilead’s Covid drug before trial results
Can we actually learn to live with coronavirus? Not until we have a vaccine
Takeda group begins manufacturing Covid-19 plasma treatment ahead of approval
Covid-19 antibodies last at least three months; so do symptoms for many
Remdesivir study finally published – an expert in critical care medicine gives us his verdict
Opko’s BioReference Lab Begins Covid-19 Testing At NYC Schools
Kymera Therapeutics Pops 10% On Positive Skin Disorder Data
Eli Lilly In Gates Foundation Supply Deal For Covid-19 Antibodies
Pfizer, BioNTech Initiate Rolling Canada Submission For Covid-19 Vaccine
AstraZeneca Inks $486M US Support For Covid-19 Antibody Cocktail